NCM
CBAY
Nantahala Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-553,307
| Closed | -$6.06M | – | 132 |
|
|
2023
Q2 | $6.06M | Sell |
553,307
-1,236,796
| -69% | -$13.5M | 0.59% | 37 |
|
|
2023
Q1 | $15.6M | Sell |
1,790,103
-460,456
| -20% | -$4.02M | 1.2% | 20 |
|
|
2022
Q4 | $14.1M | Sell |
2,250,559
-224,100
| -9% | -$1.41M | 0.91% | 24 |
|
|
2022
Q3 | $8.66M | Sell |
2,474,659
-169,647
| -6% | -$594K | 0.56% | 34 |
|
|
2022
Q2 | $7.8M | Buy |
2,644,306
+750,309
| +40% | +$2.21M | 0.39% | 37 |
|
|
2022
Q1 | $5.89M | Sell |
1,893,997
-106,145
| -5% | -$330K | 0.26% | 51 |
|
|
2021
Q4 | $6.76M | Buy |
+2,000,142
| New | +$6.76M | 0.24% | 54 |
|